1st Quarter - Report
MAGILL ASSOCIATES, LLC for THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES
Income
—
Expenses
—
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY 2027 appropriations for the development of a synthetic vaccine
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN PIERSON MAGILL | COS to Rep. Wally Herger |
Medical/Disease Research/Clinical Labs MED
FY 2027 appropriations for the development of a synthetic vaccine
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN PIERSON MAGILL | COS to Rep Wally Herger |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.